PDA Technical Report No. 84 (TR 84) Integrating Data Integrity Requirements into Manufacturing & Packaging Operations (single user digital version)
Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.
- Format
- PDF Single user
- Member Price
- $180.00
- Nonmember Price
- $325.00
- Government Price
- $180.00
Please sign in or become a member to purchase items from the PDA bookstore.
PDA Technical Report No. 84 (TR 84): Integrating Data Integrity Requirements into Manufacturing and Packaging Operations addresses data integrity from the perspective of manufacturing operations. It discusses regulatory trends, risk management concepts, and recommendations for implementing appropriate data integrity controls in manufacturing operations applicable to paper-based, electronic-based, and hybrid systems. The case studies included in this technical report provide examples of how to assess current data integrity risks and implement the concepts presented in the report.
This technical report describes an approach using quality risk management (QRM) for establishing and assessing the appropriateness of data integrity controls for each manufacturing operation based on the criticality and vulnerability of the data for its intended use.
Table of Contents
Table of Contents:
Click here to download >>> Detailed Table of Contents- Introduction and Scope
- Glossary and Abbreviations
- Data Integrity Trends at International Drug Manufacturers
- Quality Risk Management Applied to Data Integrity
- Data Integrity Controls
- Controls for Big Data as it Relates to Data Integrity
- References
- Annex 1: Examples — How to use the 9-Box Vulnerability Grid
Figures and Tables Index
About the Authors
Els Poff, Merck
James Curry, PhD, Teva Pharmaceuticals
John Grealis, PhD, Novartis
Anne Pericone, Johnson & Johnson
Susan Schniepp, Regulatory Compliance Associates Inc.
Nader Shafiei, PhD, Sanofi
Ronald Tetzlaff, PhD, Parexel Consulting
Anthony Warchut, AC Warchut GMP Consulting
Jeffrey Broadfoot, Emergent BioSolutions, Inc.
Derek Glover, Mylan
Maryann Gribbin, Faith & Royale Consultants
Tina Morris, PhD, American Association of Pharmaceutical Scientists
Rebecca Parrilla, U.S. Food and Drug Administration
Carmelo Rosa, PsyD, U.S. Food and Drug Administration
Anil Sawant, PhD, Merck
Christopher Smalley, PhD, ValSource, LLC